48 hasil
Menampilkan 1–20 · 0,20 detik · RSS
Blood Global Hematology
ISSN 3050-5658 · Elsevier · 48 artikel di indeks
-
Artikel Jurnal
LymphGen molecular subtyping reveals therapeutic heterogeneity beyond cell-of-origin classification in Indian DLBCL
Abstract: Diffuse large B-cell lymphoma (DLBCL) is molecularly heterogeneous, yet standard cell-of-origin (COO) classification fails to capture actionable biology. Systematic genetic profiling remains unmapped in South Asian populations, who exhibit an age of onset a decade younger. We performed…
-
Artikel Jurnal
Epidemiology, treatment patterns, and survival of chronic myeloid leukemia in Colombia: a real-world cohort study (2018-2023)
Abstract: The introduction of tyrosine kinase inhibitors (TKIs) has transformed chronic myeloid leukemia (CML) into a chronic condition. However, contemporary population-level data from Latin America remain scarce. We performed a retrospective, population-based cohort study including adults with…
-
Artikel Jurnal
Outcomes and clinical characteristics of acute promyelocytic leukemia in Kuwait: a 15-year national cohort study
Abstract: Acute promyelocytic leukemia (APL) is a highly curable subtype of acute myeloid leukemia since the introduction of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO), yet Middle Eastern data are limited. We report, to our knowledge, the first national APL cohort from the Arabian…
-
Artikel Jurnal
Health care funding and education independently predict survival in DLBCL: a large real-world study from Brazil
Abstract: In real-world settings, diffuse large B-cell lymphoma (DLBCL) outcomes may be influenced by health care system characteristics and socioeconomic factors. Brazil’s dual system includes a government-funded public system and a supplementary private sector. However, their impact on DLBCL…
-
Artikel Jurnal
Platelet indices as accessible biomarkers for risk stratification in pediatric sickle cell disease: a Kenyan cohort study
Abstract: Sickle cell disease (SCD) is a significant health challenge in Kenya, often associated with complications that result in 50% to 90% mortality if undiagnosed. This necessitates accessible phenotype-based biomarkers for risk stratification in resource-limited settings that offer primary…
-
Artikel Jurnal
Hematological malignancies in North Africa: contemporary estimates and projections for 2050
Abstract: Hematological malignancies are a major contributor to cancer morbidity and mortality in North Africa, yet regional epidemiologic data remain limited. The region’s distinct demographic, sociocultural, and health care characteristics underscore the need for contemporary, country-specific…
-
Artikel Jurnal
Next-generation sequencing implementation in Mexican adults with acute myeloid leukemia
Abstract: Comprehensive genomic analysis is essential for risk stratification and therapeutic decision-making in acute myeloid leukemia (AML). However, access to next-generation sequencing (NGS) remains limited in low- and middle-income countries. We conducted a single-center prospective cohort…
-
Artikel Jurnal
Field evaluation of the Sickle Confirm point-of-care test for hemoglobin S and zygosity in sub-Saharan Africa
Abstract: Sickle cell disease remains underdiagnosed in sub-Saharan Africa due to limited access to reliable, affordable, and field-adapted diagnostic tools. In this study, we aimed to independently assess the diagnostic performance of the Sickle Confirm test under routine clinical conditions in…
-
Artikel Jurnal
ETV6::FLT3 fusion as an unfavorable prognostic factor in an AYA patient with B-ALL
Abstract: B-cell acute lymphoblastic leukemia (B-ALL) is a genetically heterogeneous disease in which molecular characterization guides prognosis and treatment. We report, to our knowledge, the first known case of B-ALL in an adolescent and young adult patient harboring an ETV6::FLT3 fusion. A…
-
Artikel Jurnal
Clinical practice guidelines for the diagnosis and management of Hodgkin lymphoma in countries with restricted resources
Background: Classical Hodgkin lymphoma (cHL) is a highly curable malignancy but presents a significant health challenge in low- to middle-income countries (LMICs), where resource constraints, lack of novel therapies, and advanced diagnostics hinder effective treatments, particularly in relapsed…
-
Artikel Jurnal
Twenty-five years of tyrosine kinase inhibitors for chronic myeloid leukemia in Brazil
Abstract: Twenty-five years ago tyrosine kinase inhibitors (TKIs) revolutionized treatment by significantly improving survival and transforming chronic myeloid leukemia (CML) into a controllable chronic condition for many patients. It marked the beginning of a new era in oncology, representing the…
-
Artikel Jurnal
Clinical outcomes of patients with chronic myeloid leukemia with asciminib provided by a compassionate program in Brazil
Abstract: This study evaluated the clinical outcomes of patients with chronic myeloid leukemia (CML) treated with asciminib, a first-in-class allosteric inhibitor that selectively targets the ABL myristoyl pocket (STAMP) of BCR::ABL1. Through Novartis’s Managed Access Program in Brazil, asciminib…
-
Artikel Jurnal
Development of disease-specific growth curves from Kenyan children with sickle cell anemia
Abstract: Sickle cell anemia (SCA) is a life-threatening hemoglobinopathy with worldwide distribution. Featuring multiple acute and chronic complications, SCA is also associated with growth impairment. A lack of appropriate reference data on height, weight, and body mass index (BMI) impedes…
-
Artikel Jurnal
From donor to diagnosis: using blood banks to estimate MGUS prevalence in a Mexican population
Abstract: Monoclonal gammopathy of undetermined significance (MGUS) is a common plasma cell disorder and precursor to multiple myeloma (MM). While MGUS precedes nearly all MM cases, most individuals remain stable without progression. Its prevalence varies by age, sex, and ethnicity, with lower…
-
Artikel Jurnal
Neurocognitive functioning of patients with sickle cell disease in low- and middle-income countries
Abstract: Sickle cell disease (SCD) is a monogenic blood disorder that affects the production of hemoglobin. Patients with SCD display slowed neurocognitive development resulting from a combination of cerebrovascular complications and sociodemographic factors. In low- and middle-income countries…
-
Artikel Jurnal
Circulating plasma EBV DNA: a potential tool to facilitate diagnosis of pediatric Burkitt lymphoma in sub-Saharan Africa
Abstract: In sub-Saharan Africa (SSA), many pediatric patients with Burkitt lymphoma (BL) perish because of diagnostic delays. About 95% of pediatric BL cases in SSA are Epstein-Barr virus (EBV) positive. We assessed plasma EBV DNA in 400 pediatric patients with BL and 400 controls…